Online Medical Consultation

Connect with a state-licensed physicians from the comfort of your home – no travel or waiting rooms

Physician-Supervised Treatment

Our medical professionals ensure your weight loss journey is safe, effective, and tailored to your needs

Get Tirzepatide Today
women on Tirzepatide

Lose Weight in 3 Steps

Free Online Consultation

Schedule your complimentary initial assessment through our secure portal.

Physician Evaluation

Connect via video call with our Alabama-licensed doctors for personalized care.

Receive Medication, Ongoing Support

If approved, your Tirzepatide is delivered directly to your door. Regular follow-ups and continuous access to our medical team.

The Plan

plan

Monthly Package

Weekly Tirzepatide injections Licensed physician supervision Comprehensive health monitoring Cancel anytime flexibility No membership fees or hidden costs $399/month

plan

3-Month Package

Complete 3-month medication supply Quarterly health assessments Priority access to medical team Save $175 off retail price $1,125 total

plan

6-Month Package

Maximum savings package Bi-monthly health assessments Premium medical support Complementary nutritional guidance Save $401 off retail price $2,199 total

Testimonials

Start From $399/Month - Begin Your Transformation Today

Begin your weight loss transformation today for just $399/month with our physician-supervised Tirzepatide treatment. With no hidden fees, free shipping, and measurable results often seen within the first month, there’s never been a better time to invest in your health and start losing weight with the science-backed solution that works.

Start Free Evaluation

Tirzepatide Comparison with other weight loss medications (e.g., Semaglutide, Wegovy, Ozempic).

Feature Tirzepatide (Mounjaro, Zepbound) Semaglutide (Ozempic, Rybelsus) Wegovy Ozempic
Medication Type Dual GIP/GLP-1 Agonist GLP-1 Agonist GLP-1 Agonist GLP-1 Agonist
FDA Approved For Type 2 Diabetes, Obesity* Type 2 Diabetes Chronic Weight Management Type 2 Diabetes
Dosing Schedule Weekly Injection Weekly Injection/Oral Weekly Injection Weekly Injection
Average Weight Loss Up to 25–35%¹ Up to 15%² Up to 15%² Up to 14%³
Mechanism GIP + GLP-1 Receptor Agonist GLP-1 Receptor Agonist GLP-1 Receptor Agonist GLP-1 Receptor Agonist
Available Forms Injection Injection, Tablet Injection Injection
FDA Approval Year 2022 (diabetes), 2023 (obesity) 2017 (Ozempic), 2019 (Rybelsus) 2021 2017
Insurance Coverage Varies Varies Varies Varies